Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.

Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q38046319
Genetics of myeloproliferative neoplasmsThe NF1 somatic mutational landscape in sporadic human cancers.A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages.The new landscape of therapy for myelofibrosis.Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.Molecular genetics of myelofibrosis and its associated disease phenotypes.Molecular pathology of myelodysplastic syndromes: new developments and implications for diagnosis and treatment.Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.Epigenetics in Myeloproliferative Neoplasms.TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms.
P2860

Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q38046319
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.
@en
type
label
Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.
@en
prefLabel
Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932